Lupus Nephritis

With many patients avoiding in-office visits due to COVID-19 concerns, self-management in lupus is more important than ever, according to a presenter at the 2020 Rheumatology Nurses Society Annual Conference.

A lack of EULAR/European Renal Association-European Dialysis and Transplant Association response at 1 year among patients with lupus nephritis predicted chronic kidney disease, researchers reported.

Data from the largest lupus nephritis study to date suggested that belimumab plus standard therapy “significantly improves” renal response compared with standard therapy alone, according to data presented at the EULAR 2020 Congress.

Learning Objectives:

Tacrolimus maintenance over 5 years is well-tolerated and effective among patients with lupus nephritis, according to data published in The Journal of Rheumatology.

Treatment goals for lupus nephritis should include complete response by 12 months, according to updated recommendations published by EULAR, along with the European Renal Association–European Dialysis and Transplant Association, in the Annals of the Rheumatic Diseases.

Phase 3 results from the AURORA study indicate treatment with the immunosuppressant drug voclosporin was superior to standard of care for achieving renal response rates in patients with lupus nephritis. The results were presented virtually at the National Kidney Foundation Spring Clinical Meetings.

To a nonmedical professional, the placebo effect is a fairly straightforward concept: give someone a sugar pill, tell them it is medicine, they think they get better. But the reality of what the placebo effect has come to mean in the current health care setting is something entirely different, and more complicated.

SCOTTSDALE, Ariz. — Characteristic microbiome imbalances in patients with lupus could potentially act as both the cause and effect of high lupus disease activity, according to Gregg Silverman, MD, of the New York University School of Medicine.

Patients of lower socioeconomic status, determined through area-level household income, had a greater incidence of both ANCA-related glomerulonephritis and lupus nephritis, according to study results from British Columbia, Canada.